SEC Form 4 · accession 0001491519-18-000001
AMERICAN BIO MEDICA CORP · ABMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chaim Davis
Director
Period of report
Jun 21, 2018
Accepted (ET)
Jun 27, 2018 · 9:58 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896747
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Jun 21, 2018 | A | 33,784 | $0.10 | A | 58,507 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non Statutory Stock OptionF2,F3 | $0.10 | Jun 21, 2018 | J | 20,000 | A | Jun 21, 2019 | Jun 21, 2028 | Common Shares | 20,000 | 20,000 | D |
Explanation of responses
- F133,784 shares of restricted stock were issued to Davis as compensation for his attendance at a meeting of the Board of Directors held in June 2018. This stock issuance is in accordance with the director compensation structure approved by the Company's Board of Directors on March 22, 2018 (as indicated in the Company's Proxy Statement filed on April 20, 2018).
- F2The closing price of the Company's common shares on June 21, 2018 was $0.10.
- F3The stock option becomes 100% exercisable on June 21, 2019.